These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9313951)

  • 41. 6-(2-Furanyl)-9H-purin-2-amine derivatives as A2A adenosine antagonists.
    Kiselgof E; Tulshian DB; Arik L; Zhang H; Fawzi A
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2119-22. PubMed ID: 15808481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor.
    Michielan L; Bacilieri M; Schiesaro A; Bolcato C; Pastorin G; Spalluto G; Cacciari B; Klotz KN; Kaseda C; Moro S
    J Chem Inf Model; 2008 Feb; 48(2):350-63. PubMed ID: 18215030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
    Baraldi PG; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Romagnoli R; Moorman AR; Varani K; Borea PA; Preti D
    Bioorg Med Chem; 2012 Jan; 20(2):1046-59. PubMed ID: 22204739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies.
    Franchetti P; Cappellacci L; Marchetti S; Trincavelli L; Martini C; Mazzoni MR; Lucacchini A; Grifantini M
    J Med Chem; 1998 May; 41(10):1708-15. PubMed ID: 9572897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation.
    Varani K; Laghi-Pasini F; Camurri A; Capecchi PL; Maccherini M; Diciolla F; Ceccatelli L; Lazzerini PE; Ulouglu C; Cattabeni F; Borea PA; Abbracchio MP
    FASEB J; 2003 Feb; 17(2):280-2. PubMed ID: 12475889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Signaling via A2A adenosine receptor in four PC12 cell clones.
    Arslan G; Kull B; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):28-32. PubMed ID: 9933147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigations.
    Pastorin G; Da Ros T; Bolcato C; Montopoli C; Moro S; Cacciari B; Baraldi PG; Varani K; Borea PA; Spalluto G
    J Med Chem; 2006 Mar; 49(5):1720-9. PubMed ID: 16509587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 125I-APE binding to adenosine receptors in coronary artery: photoaffinity labeling with 125I-azidoAPE.
    Hussain T; Linden J; Mustafa SJ
    J Pharmacol Exp Ther; 1996 Jan; 276(1):284-8. PubMed ID: 8558444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists.
    Yang M; Soohoo D; Soelaiman S; Kalla R; Zablocki J; Chu N; Leung K; Yao L; Diamond I; Belardinelli L; Shryock JC
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):133-44. PubMed ID: 17310264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
    Poulsen SA; Quinn RJ
    J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5'-N-ethylcarboxamide[3H]adenosine binding sites of mouse mastocytoma P815 cell membranes: characterization and solubilization.
    Nakata H; Fujisawa H
    J Biochem; 1989 Jun; 105(6):888-93. PubMed ID: 2504705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel 8-(furan-2-yl)-3-benzyl thiazolo [5,4-e][1,2,4] triazolo [1,5-c] pyrimidine-2(3H)-thione as selective adenosine A(2A) receptor antagonist.
    Barodia SK; Mishra CB; Prakash A; Senthil Kumar JB; Kumari N; Luthra PM
    Neurosci Lett; 2011 Jan; 488(1):1-5. PubMed ID: 20708066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain.
    Lindström K; Ongini E; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):539-41. PubMed ID: 8897460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
    Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Monopoli A; Ongini E; Varani K; Borea PA
    J Med Chem; 2002 Jan; 45(1):115-26. PubMed ID: 11754583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.
    Fredholm BB; Lindström K
    Eur J Pharmacol; 1999 Sep; 380(2-3):197-202. PubMed ID: 10513579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression.
    Hodgson RA; Bertorelli R; Varty GB; Lachowicz JE; Forlani A; Fredduzzi S; Cohen-Williams ME; Higgins GA; Impagnatiello F; Nicolussi E; Parra LE; Foster C; Zhai Y; Neustadt BR; Stamford AW; Parker EM; Reggiani A; Hunter JC
    J Pharmacol Exp Ther; 2009 Jul; 330(1):294-303. PubMed ID: 19332567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of adenosine A2 receptors in bovine retinal pigment epithelial membranes.
    Blazynski C
    Exp Eye Res; 1993 May; 56(5):595-9. PubMed ID: 8500568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices.
    Tebano MT; Domenici MR; Popoli P
    Eur J Pharmacol; 2002 Aug; 450(3):253-7. PubMed ID: 12208317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding thermodynamics of adenosine A2a receptor ligands.
    Borea PA; Dalpiaz A; Varani K; Guerra L; Gilli G
    Biochem Pharmacol; 1995 Feb; 49(4):461-9. PubMed ID: 7532939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Caffeine alters A2A adenosine receptors and their function in human platelets.
    Varani K; Portaluppi F; Merighi S; Ongini E; Belardinelli L; Borea PA
    Circulation; 1999 May; 99(19):2499-502. PubMed ID: 10330379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.